iCell® Neurons Enable Alzheimer’s Disease ModelingResearch demonstrate potential use of iCell® Neurons in high throughput screening at GlaxoSmithKline.
Galapagos Discovers Novel Candidate Drug to Treat Breast CancerGLPG1790 has high efficacy against triple-negative breast cancer.
A Molecular-Modeling Toolbox Aimed at Bridging the Gap Between Medicinal Chemistry and Computational SciencesResearchers from the University of Basel have designed a versatile single-click tools to assist medicinal chemists in performing two routine modeling tasks.
Chemists Find Help from Nature in Fighting CancerStudy of several dozen compounds based on a fungal chemical shows potent anti-tumor activity.
Gallo Center Scientists Identify Potential New Mechanism for Treating Problem DrinkingResearchers identified a potential new approach for reducing problem drinking: a new family of drugs with the ability to manipulate DNA structure without changing it.
€9m EU-project on Deep-Sea Organisms StartedThe PharmaSea project will evaluate the potential of new bioactive compounds from marine organisms as novel drug leads or ingredients for nutrition or cosmetic applications.
Anti-cancer Drug Discovery and Development: Bcl-2 Family Small Molecule InhibitorsIn this article, researchers from The Pennsylvania University College of Medicine discuss the current status of Bcl-2 family small molecule inhibitors in preclinical and clinical development.
Chemists Devise Inexpensive, Benchtop Method for Marking and Selecting CellsChemists at The Scripps Research Institute have found an easier way to perform one of the most fundamental tasks in molecular biology.
Two MIT Professors Win Prestigious Wolf PrizeMichael Artin and Robert Langer honored for groundbreaking work in mathematics and chemistry.
Study Paves way to Design Drugs Aimed at Multiple Protein Targets at OncePharmaceutical chemists had suggested that the objective of a drug hitting multiple targets simultaneously is impossible and unlikely to succeed. This study shows how to efficiently and effectively make designer drugs that can do that.
